Ryerson (RYZ) Financials

$27.88 +1.66 (+6.31%)

Closing price 03:59 PM Eastern

Extended Trading

$27.89 +0.00 (+0.02%)

As of 05:04 PM Eastern

Annual Income Statements for Ryerson

This table shows Ryerson's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-0.50	19	17	106	82	-66	294	391	146	-8.60	-56
Consolidated Net Income / (Loss)	-1.80	19	18	106	83	-65	295	392	146	-7.30	-55
Net Income / (Loss) Continuing Operations	-1.80	19	18	37	83	-65	295	392	146	-7.30	-55
Total Pre-Tax Income	1.90	26	17	117	115	-90	389	523	194	-7.40	-71
Total Operating Income	109	122	101	139	211	65	545	579	228	32	-31
Total Gross Profit	568	571	583	758	828	621	1,147	1,310	1,022	834	782
Total Revenue	3,167	2,860	3,365	4,408	4,502	3,467	5,675	6,324	5,109	4,599	4,571
Operating Revenue	3,167	2,860	3,365	4,408	4,502	3,467	5,675	6,324	5,109	4,599	4,571
Total Cost of Revenue	2,600	2,289	2,782	3,650	3,674	2,846	4,529	5,014	4,087	3,765	3,789
Operating Cost of Revenue	2,600	2,289	2,782	3,650	3,674	2,846	4,529	5,014	4,087	3,765	3,789
Total Operating Expenses	459	449	481	619	617	557	602	731	794	803	813
Selling, General & Admin Expense	451	448	481	615	637	554	711	735	794	801	810
Impairment Charge	7.70	-	-	-	-	-	-	-	0.00	0.00	3.40
Restructuring Charge	2.50	1.00	0.00	4.20	2.40	2.20	-	0.00	0.00	3.10	0.00
Other Special Charges / (Income)	-1.90	-	0.00	0.00	-22	0.00	-110	-3.80	0.00	-1.60	0.00
Total Other Income / (Expense), net	-107	-96	-84	-92	-96	-155	-156	-56	-34	-39	-40
Interest Expense	96	90	91	99	93	76	155	55	35	43	39
Other Income / (Expense), net	-10	-6.10	6.60	6.90	-2.40	-78	-0.90	-1.30	0.30	4.10	-1.50
Income Tax Expense	3.70	7.20	-1.30	10	33	-25	94	131	47	-0.10	-16
Net Income / (Loss) Attributable to Noncontrolling Interest	-1.30	0.20	0.90	0.40	0.30	0.50	1.10	0.50	0.70	1.30	1.30
Basic Earnings per Share	($0.02)	$0.55	$0.46	$2.84	$2.19	($1.73)	$7.67	$10.41	$4.17	($0.26)	($1.76)
Weighted Average Basic Shares Outstanding	25M	34.30M	37.18M	37.30M	37.60M	38.12M	38.39M	36.99M	34.02M	31.85M	51.48M
Diluted Earnings per Share	($0.02)	$0.54	$0.46	$2.81	$2.17	($1.73)	$7.56	$10.21	$4.10	($0.26)	($1.76)
Weighted Average Diluted Shares Outstanding	25M	34.30M	37.18M	37.30M	37.60M	38.12M	38.39M	36.99M	34.02M	31.85M	51.48M
Weighted Average Basic & Diluted Shares Outstanding	25M	34.30M	37.18M	37.30M	37.60M	38.12M	38.39M	36.99M	34.02M	31.85M	51.48M
Cash Dividends to Common per Share	-	-	-	-	$0.00	$0.00	$0.17	$0.54	$0.72	$0.75	$0.75

This table shows Ryerson's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	38	35	26	-7.60	9.90	-6.60	-4.30	-5.60	1.90	-15	-38
Consolidated Net Income / (Loss)	38	35	26	-7.40	10	-6.00	-4.20	-5.30	2.10	-14	-38
Net Income / (Loss) Continuing Operations	38	35	26	-7.40	10	-6.00	-4.20	-5.30	2.10	-14	-38
Total Pre-Tax Income	50	48	34	-9.50	13	-6.40	-4.80	-6.90	-6.30	-10	-48
Total Operating Income	58	56	44	0.80	23	5.30	2.60	2.30	5.80	-1.00	-38
Total Gross Profit	261	249	247	218	224	202	191	204	209	200	169
Total Revenue	1,344	1,247	1,112	1,239	1,226	1,127	1,007	1,136	1,169	1,162	1,105
Operating Revenue	1,344	1,247	1,112	1,239	1,226	1,127	1,007	1,136	1,169	1,162	1,105
Total Cost of Revenue	1,083	997	865	1,022	1,002	925	816	931	960	962	936
Operating Cost of Revenue	1,083	997	865	1,022	1,002	925	816	931	960	962	936
Total Operating Expenses	203	193	204	217	201	197	189	202	204	201	207
Selling, General & Admin Expense	203	193	204	217	199	197	189	202	204	201	203
Total Other Income / (Expense), net	-8.60	-8.10	-10	-10	-9.50	-12	-7.40	-9.20	-12	-9.30	-9.80
Interest Expense	8.30	9.30	9.50	10	11	12	10	9.50	9.80	10	9.50
Other Income / (Expense), net	-0.30	1.20	-0.50	-0.20	1.80	-0.20	2.70	0.30	-2.30	0.80	-0.30
Income Tax Expense	12	13	7.50	-2.10	3.00	-0.40	-0.60	-1.60	-8.40	4.10	-10
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.30	0.20	0.20	0.40	0.60	0.10	0.30	0.20	0.40	0.40
Basic Earnings per Share	$1.07	$1.02	$0.78	($0.22)	$0.29	($0.20)	($0.13)	($0.18)	$0.06	($0.46)	($1.18)
Weighted Average Basic Shares Outstanding	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M	32.20M	32.20M	32.21M	51.48M
Diluted Earnings per Share	$1.06	$1.00	$0.77	($0.22)	$0.29	($0.20)	($0.13)	($0.18)	$0.06	($0.46)	($1.18)
Weighted Average Diluted Shares Outstanding	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M	32.20M	32.20M	32.21M	51.48M
Weighted Average Basic & Diluted Shares Outstanding	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M	32.20M	32.20M	32.21M	51.48M
Cash Dividends to Common per Share	$0.18	$0.18	$0.19	$0.19	$0.19	$0.19	$0.19	$0.19	$0.19	$0.19	$0.19

This table details how cash moves in and out of Ryerson's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	3.20	16	-8.60	-50	71	2.70	-10	-12	15	-26	-1.50
Net Cash From Operating Activities	259	25	-4.00	57	193	278	35	501	365	205	87
Net Cash From Continuing Operating Activities	259	25	-4.00	57	193	278	35	501	365	205	87
Net Income / (Loss) Continuing Operations	-1.80	19	18	106	83	-65	295	392	146	-7.30	-55
Consolidated Net Income / (Loss)	-1.80	19	18	106	83	-65	295	392	146	-7.30	-55
Depreciation Expense	44	43	47	53	58	54	56	59	63	78	80
Non-Cash Adjustments To Reconcile Net Income	26	24	0.10	78	-9.50	77	31	7.70	17	24	16
Changes in Operating Assets and Liabilities, net	191	-3.30	117	140	62	213	-347	43	139	111	46
Net Cash From Investing Activities	-18	-20	-70	-200	26	-26	94	-160	-262	-143	-54
Net Cash From Continuing Investing Activities	-18	-20	-70	-200	26	-26	94	-160	-262	-143	-54
Purchase of Property, Plant & Equipment	-22	-23	-25	-38	-46	-26	-59	-105	-122	-100	-52
Acquisitions	-8.80	-	-49	-170	0.00	0.00	-15	-57	-138	-44	0.00
Purchase of Investments	-	-	-	-	-	0.00	0.00	-2.00	0.00	0.00	0.00
Sale of Property, Plant & Equipment	10	3.20	3.80	5.90	70	0.10	166	8.00	0.50	2.10	2.60
Other Investing Activities, net	2.70	-	0.20	2.00	1.80	0.00	1.90	-3.90	-2.90	-1.10	-4.70
Net Cash From Financing Activities	-232	11	66	93	-184	-250	-138	-350	-88	-87	-37
Net Cash From Continuing Financing Activities	-232	11	66	93	-184	-250	-138	-350	-88	-87	-37
Repayment of Debt	-226	-	-0.20	-52	-191	-777	-168	-333	-640	-593	-782
Repurchase of Common Equity	-	-	-	-	0.00	0.00	-1.80	-50	-114	-51	0.00
Payment of Dividends	-	-	0.00	-0.20	0.00	-0.20	-6.40	-20	-25	-25	-24
Issuance of Debt	-	1,436	74	150	0.00	500	46	26	701	617	776
Other Financing Activities, net	-5.80	5.90	-8.40	-4.40	7.10	27	-7.70	27	-11	-34	-6.50
Effect of Exchange Rate Changes	-5.70	-	-	-	-	0.90	-1.60	-3.00	0.20	-1.50	1.60
Cash Interest Paid	87	89	85	93	88	62	51	38	30	41	41
Cash Income Taxes Paid	3.20	1.80	1.70	2.10	-6.60	-5.70	70	177	6.20	10	5.70

This table details how cash moves in and out of Ryerson's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Change in Cash & Equivalents	-14	7.40	17	-12	-14	7.60	-7.50	5.40	-2.50	-1.80	-2.60
Net Cash From Operating Activities	115	79	90	-48	26	135	92	-41	24	-8.30	113
Net Cash From Continuing Operating Activities	115	79	90	-48	26	135	92	-41	24	-8.30	113
Net Income / (Loss) Continuing Operations	38	35	26	-7.40	10	-6.00	-4.20	-5.30	2.10	-14	-38
Consolidated Net Income / (Loss)	38	35	26	-7.40	10	-6.00	-4.20	-5.30	2.10	-14	-38
Depreciation Expense	15	14	20	17	18	20	23	19	19	20	21
Non-Cash Adjustments To Reconcile Net Income	4.00	2.00	13	6.30	2.50	4.00	11	1.60	5.40	1.80	7.40
Changes in Operating Assets and Liabilities, net	59	28	31	-64	-4.90	117	63	-57	-3.10	-16	122
Net Cash From Investing Activities	-58	-23	-115	-20	-23	-75	-24	-8.00	-13	-9.90	-23
Net Cash From Continuing Investing Activities	-58	-23	-115	-20	-23	-75	-24	-8.00	-13	-9.90	-23
Purchase of Property, Plant & Equipment	-46	-22	-25	-22	-23	-32	-24	-8.00	-9.90	-13	-21
Other Investing Activities, net	-	-0.20	-2.70	0.00	-	-0.10	-0.60	-0.10	-3.30	0.60	-1.90
Net Cash From Financing Activities	-70	-49	41	56	-17	-52	-75	54	-14	16	-93
Net Cash From Continuing Financing Activities	-70	-49	41	56	-17	-52	-75	54	-14	16	-93
Repayment of Debt	-2.40	-2.10	-2.40	-2.00	-3.80	-1.50	-1.30	-1.40	-1.40	-554	-225
Payment of Dividends	-6.20	-6.30	-6.30	-6.40	-6.40	-6.00	-6.00	-6.00	-6.00	-6.00	-6.10
Issuance of Debt	1.00	-30	71	61	29	-3.60	-55	30	15	543	189
Other Financing Activities, net	-12	-6.80	-15	4.60	-22	-4.90	-12	32	-21	33	-50
Effect of Exchange Rate Changes	-1.70	-	1.20	-0.40	-0.20	0.40	-1.30	0.20	0.70	-	0.70
Cash Interest Paid	6.80	7.80	9.20	11	9.60	12	8.40	9.30	9.80	11	11
Cash Income Taxes Paid	3.30	1.30	-0.40	6.40	1.10	1.00	1.80	1.90	1.00	1.90	0.90

This table presents Ryerson's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	1,545	1,559	1,712	2,086	2,022	1,802	2,366	2,334	2,570	2,440	2,405
Total Current Assets	959	998	1,104	1,413	1,280	1,103	1,593	1,442	1,383	1,208	1,223
Cash & Equivalents	63	81	77	23	11	61	51	39	54	28	27
Restricted Cash	1.20	1.00	1.10	1.10	49	1.10	1.20	1.30	1.10	1.60	0.90
Accounts Receivable	306	326	376	521	425	379	631	514	468	426	461
Inventories, net	556	563	617	806	743	605	832	799	783	685	648
Prepaid Expenses	33	27	33	62	52	58	78	88	78	68	86
Plant, Property, & Equipment, net	400	388	423	489	440	422	388	458	590	637	610
Total Noncurrent Assets	186	173	185	184	302	277	384	434	597	595	572
Goodwill	103	103	115	120	120	120	124	129	158	162	162
Intangible Assets	46	41	47	58	51	43	42	51	74	68	58
Other Noncurrent Operating Assets	5.00	4.30	5.00	5.80	131	113	218	254	365	365	352
Total Liabilities & Shareholders' Equity	1,545	1,559	1,712	2,086	2,022	1,802	2,366	2,334	2,570	2,440	2,405
Total Liabilities	1,686	1,608	1,719	2,010	1,843	1,657	1,821	1,441	1,655	1,615	1,641
Total Current Liabilities	316	332	403	569	492	528	751	619	634	580	668
Short-Term Debt	22	19	21	27	49	14	29	5.80	8.20	0.70	1.90
Accounts Payable	206	230	275	390	312	365	481	438	463	441	516
Accrued Expenses	36	28	48	134	94	121	210	145	128	103	113
Current Employee Benefit Liabilities	35	45	48	7.90	7.00	6.60	6.10	4.80	4.00	3.70	3.70
Other Current Liabilities	-	-	-	0.00	21	21	25	25	31	32	34
Total Noncurrent Liabilities	1,370	1,276	1,317	1,441	1,351	1,129	1,070	822	1,021	1,035	973
Long-Term Debt	1,002	944	1,024	1,126	933	726	611	361	428	467	461
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	13	65	58	94	114	136	129	110
Noncurrent Employee Benefit Liabilities	328	299	244	258	218	232	163	118	107	91	70
Other Noncurrent Operating Liabilities	41	33	49	44	136	20	202	229	351	348	331
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-141	-49	-7.40	76	179	145	545	893	915	825	764
Total Preferred & Common Equity	-142	-51	-10	73	173	139	537	885	906	815	753
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-142	-51	-10	73	173	139	537	885	906	815	753
Common Stock	303	376	378	381	382	384	389	398	412	424	433
Retained Earnings	-131	-112	-95	14	100	34	322	693	813	780	699
Treasury Stock	-6.60	-6.60	-6.60	-6.60	-6.60	-6.60	-8.40	-61	-179	-234	-237
Accumulated Other Comprehensive Income / (Loss)	-307	-308	-286	-316	-302	-272	-165	-144	-140	-154	-142
Noncontrolling Interest	0.70	1.50	2.60	2.70	6.00	6.30	7.40	7.90	8.60	9.20	11

This table presents Ryerson's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025
Total Assets	2,547	2,402	2,522	2,434	2,720	2,591	2,533	2,524	2,538	2,490
Total Current Assets	1,701	1,457	1,448	1,359	1,525	1,389	1,301	1,298	1,325	1,304
Cash & Equivalents	51	44	30	37	42	28	35	34	31	30
Restricted Cash	1.20	1.30	1.10	1.10	1.10	1.20	1.80	1.10	1.40	0.60
Accounts Receivable	646	615	581	545	549	529	500	528	533	521
Inventories, net	933	711	754	699	841	744	681	657	676	679
Prepaid Expenses	70	85	83	76	93	87	84	78	84	74
Plant, Property, & Equipment, net	428	486	532	544	595	603	635	628	619	607
Plant, Property & Equipment, gross	854	938	994	1,011	1,081	1,099	1,135	1,159	1,164	1,157
Accumulated Depreciation	426	452	462	467	487	495	500	531	545	550
Total Noncurrent Assets	418	459	542	532	600	599	597	598	594	579
Goodwill	125	135	136	136	161	161	160	162	162	162
Intangible Assets	41	64	63	60	71	69	71	66	64	61
Other Noncurrent Operating Assets	252	259	343	335	368	369	366	370	369	357
Total Liabilities & Shareholders' Equity	2,547	2,402	2,522	2,434	2,720	2,591	2,533	2,524	2,538	2,490
Total Liabilities	1,655	1,521	1,655	1,543	1,823	1,705	1,691	1,710	1,717	1,693
Total Current Liabilities	705	665	712	634	729	583	585	647	651	657
Short-Term Debt	9.60	4.00	3.50	5.90	3.70	1.40	1.80	0.30	1.40	1.50
Accounts Payable	511	522	557	478	580	439	444	508	506	515
Accrued Expenses	92	71	73	72	111	69	104	66	67	104
Current Employee Benefit Liabilities	68	42	49	49	4.00	43	4.00	3.70	43	3.80
Other Current Liabilities	25	26	29	29	30	30	32	69	33	33
Total Noncurrent Liabilities	950	855	943	910	1,094	1,122	1,106	1,063	1,066	1,036
Long-Term Debt	467	391	393	360	494	524	520	497	509	498
Noncurrent Deferred & Payable Income Tax Liabilities	99	119	125	131	141	139	136	130	128	123
Noncurrent Employee Benefit Liabilities	153	112	112	111	106	103	97	83	81	78
Other Noncurrent Operating Liabilities	231	233	314	308	354	356	353	353	348	337
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	893	881	866	891	897	886	842	813	821	797
Total Preferred & Common Equity	885	873	858	883	889	878	833	804	812	787
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	885	873	858	883	889	878	833	804	812	787
Common Stock	396	401	404	408	416	420	423	428	431	430
Retained Earnings	723	734	765	794	799	803	790	768	764	743
Treasury Stock	-60	-118	-169	-173	-184	-198	-234	-237	-237	-237
Accumulated Other Comprehensive Income / (Loss)	-173	-144	-142	-146	-142	-146	-146	-155	-146	-149
Noncontrolling Interest	7.60	8.00	8.10	8.30	8.70	8.50	9.10	9.40	9.70	10

This table displays calculated financial ratios and metrics derived from Ryerson's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-12.56%	-9.71%	17.66%	31.02%	2.11%	-22.99%	63.71%	11.42%	-19.21%	-9.98%	-0.60%
EBITDA Growth	12.53%	11.70%	-2.33%	28.55%	34.07%	-84.93%	1,393.03%	6.03%	-54.29%	-61.09%	-58.13%
EBIT Growth	21.99%	18.13%	-7.16%	35.65%	42.64%	-106.57%	4,072.99%	6.08%	-60.44%	-84.41%	-190.73%
NOPAT Growth	-270.11%	185.94%	23.25%	16.47%	19.24%	-70.12%	815.32%	4.68%	-60.21%	-87.21%	-197.78%
Net Income Growth	93.13%	1,150.00%	-4.76%	491.11%	-22.27%	-178.96%	552.37%	32.53%	-62.61%	-104.99%	-654.79%
EPS Growth	98.02%	2,800.00%	-14.81%	510.87%	-22.78%	-179.72%	536.99%	35.05%	-59.84%	-106.34%	-576.92%
Operating Cash Flow Growth	453.21%	-90.42%	-116.13%	1,535.00%	236.41%	43.92%	-87.41%	1,332.00%	-27.15%	-43.88%	-57.54%
Free Cash Flow Firm Growth	55.66%	-48.01%	-123.16%	-537.27%	316.90%	-6.45%	-17.37%	74.37%	-72.11%	-42.83%	-23.45%
Invested Capital Growth	-23.54%	1.01%	15.14%	25.26%	-8.63%	-17.51%	23.58%	7.78%	6.24%	-2.55%	-5.05%
Revenue Q/Q Growth	-5.93%	0.47%	3.97%	8.61%	-4.22%	-3.03%	13.63%	-3.74%	-3.33%	-2.23%	2.18%
EBITDA Q/Q Growth	-22.67%	14.44%	8.40%	-22.96%	59.76%	-76.63%	121.48%	-28.94%	35.24%	-23.67%	-48.87%
EBIT Q/Q Growth	-28.84%	19.71%	9.90%	-29.79%	94.77%	-111.67%	150.71%	-31.07%	46.22%	-51.43%	-388.39%
NOPAT Q/Q Growth	-212.96%	2.00%	5.78%	5.22%	17.50%	-44.88%	37.88%	-23.44%	42.48%	-58.90%	-417.53%
Net Income Q/Q Growth	-107.44%	215.00%	93.55%	0.38%	45.09%	-191.52%	71.35%	-24.97%	51.55%	-131.88%	-152.75%
EPS Q/Q Growth	-103.03%	200.00%	142.11%	0.72%	45.64%	-188.33%	71.82%	-24.09%	45.91%	-140.63%	-147.89%
Operating Cash Flow Q/Q Growth	68.12%	-42.86%	91.23%	125.98%	-23.31%	-22.66%	138.63%	17.54%	-20.04%	1.04%	30.83%
Free Cash Flow Firm Q/Q Growth	0.00%	-43.32%	-187.34%	54.46%	-15.80%	-42.40%	213.87%	11.95%	-56.21%	199.83%	-37.47%
Invested Capital Q/Q Growth	-9.85%	-3.24%	1.84%	-8.81%	-4.05%	11.28%	6.76%	-7.43%	6.33%	-4.87%	-5.35%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	17.92%	19.95%	17.31%	17.20%	18.39%	17.92%	20.21%	20.72%	20.00%	18.14%	17.11%
EBITDA Margin	4.48%	5.54%	4.60%	4.51%	5.93%	1.16%	10.58%	10.06%	5.69%	2.46%	1.04%
Operating Margin	3.43%	4.27%	3.00%	3.16%	4.68%	1.86%	9.61%	9.15%	4.46%	0.69%	-0.67%
EBIT Margin	3.10%	4.06%	3.20%	3.31%	4.63%	-0.40%	9.59%	9.13%	4.47%	0.77%	-0.71%
Profit (Net Income) Margin	-0.06%	0.66%	0.54%	2.41%	1.84%	-1.88%	5.21%	6.19%	2.87%	-0.16%	-1.21%
Tax Burden Percent	-94.74%	72.41%	107.78%	91.17%	71.79%	72.48%	75.92%	74.87%	75.58%	98.65%	77.39%
Interest Burden Percent	1.93%	22.50%	15.51%	79.88%	55.28%	657.66%	71.49%	90.56%	84.81%	-20.79%	220.43%
Effective Tax Rate	194.74%	27.59%	-7.78%	8.83%	28.21%	0.00%	24.08%	25.13%	24.42%	0.00%	0.00%
Return on Invested Capital (ROIC)	-10.69%	10.55%	12.03%	11.62%	13.02%	4.46%	40.44%	36.86%	13.71%	1.72%	-1.75%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.46%	3.10%	2.29%	9.68%	6.39%	-8.52%	22.98%	27.71%	6.36%	-5.44%	-9.43%
Return on Net Nonoperating Assets (RNNOA)	12.05%	-30.43%	-75.52%	299.04%	51.97%	-44.81%	45.22%	17.61%	2.49%	-2.56%	-5.19%
Return on Equity (ROE)	1.36%	-19.88%	-63.49%	310.66%	64.99%	-40.35%	85.66%	54.47%	16.20%	-0.84%	-6.94%
Cash Return on Invested Capital (CROIC)	15.99%	9.55%	-2.05%	-10.81%	22.03%	23.66%	19.35%	29.37%	7.66%	4.30%	3.42%
Operating Return on Assets (OROA)	5.75%	7.47%	6.59%	7.69%	10.15%	-0.72%	26.12%	24.57%	9.32%	1.42%	-1.33%
Return on Assets (ROA)	-0.11%	1.22%	1.10%	5.60%	4.03%	-3.42%	14.18%	16.66%	5.97%	-0.29%	-2.27%
Return on Common Equity (ROCE)	1.38%	-20.12%	-68.08%	286.62%	62.77%	-38.81%	83.96%	53.89%	16.05%	-0.83%	-6.85%
Return on Equity Simple (ROE_SIMPLE)	1.27%	-37.20%	-180.00%	145.36%	47.91%	-47.05%	54.99%	44.23%	16.16%	-0.90%	0.00%
Net Operating Profit after Tax (NOPAT)	-103	88	109	127	151	45	414	433	172	22	-22
NOPAT Margin	-3.25%	3.09%	3.24%	2.88%	3.36%	1.30%	7.29%	6.85%	3.37%	0.48%	-0.47%
Net Nonoperating Expense Percent (NNEP)	-9.24%	7.45%	9.74%	1.94%	6.63%	12.99%	17.46%	9.15%	7.35%	7.17%	7.68%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	34.39%	12.76%	1.71%	-1.76%
Cost of Revenue to Revenue	82.08%	80.05%	82.69%	82.80%	81.61%	82.08%	79.79%	79.28%	80.00%	81.86%	82.89%
SG&A Expenses to Revenue	14.23%	15.65%	14.31%	13.94%	14.15%	15.99%	12.53%	11.63%	15.53%	17.42%	17.71%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	14.50%	15.68%	14.31%	14.04%	13.71%	16.05%	10.60%	11.57%	15.53%	17.45%	17.78%
Earnings before Interest and Taxes (EBIT)	98	116	108	146	208	-14	544	577	228	36	-32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	142	159	155	199	267	40	600	636	291	113	47
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	3.05	2.44	3.52	1.76	1.20	1.27	0.72	1.08
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	247.26	0.00	2.55	1.50	1.70	1.01	1.52
Price to Revenue (P/Rev)	0.04	0.16	0.11	0.05	0.09	0.14	0.17	0.17	0.22	0.13	0.18
Price to Earnings (P/E)	0.00	24.93	21.28	2.11	5.10	0.00	3.22	2.71	7.87	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.67%	1.87%	2.14%	4.05%	2.98%
Earnings Yield	0.00%	4.01%	4.70%	47.48%	19.60%	0.00%	31.09%	36.86%	12.70%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.32	1.60	1.38	1.12	1.21	1.38	1.36	1.14	1.19	0.82	1.05
Enterprise Value to Revenue (EV/Rev)	0.35	0.47	0.40	0.31	0.30	0.37	0.27	0.22	0.30	0.23	0.27
Enterprise Value to EBITDA (EV/EBITDA)	7.76	8.51	8.62	6.81	5.05	31.49	2.57	2.19	5.28	9.16	26.50
Enterprise Value to EBIT (EV/EBIT)	11.21	11.63	12.38	9.27	6.47	0.00	2.83	2.42	6.73	29.12	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	15.26	12.24	10.68	8.91	27.99	3.72	3.22	8.92	47.02	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	4.25	54.41	0.00	23.61	6.98	4.55	44.03	2.78	4.21	5.06	14.44
Enterprise Value to Free Cash Flow (EV/FCFF)	7.15	16.86	0.00	0.00	5.26	5.28	7.78	4.04	15.96	18.83	29.81
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-7.27	-19.54	-141.31	15.20	5.50	5.74	1.17	0.41	0.48	0.57	0.61
Long-Term Debt to Equity	-7.11	-19.15	-138.43	14.84	5.22	5.65	1.12	0.40	0.47	0.57	0.60
Financial Leverage	-8.28	-9.82	-32.96	30.89	8.13	5.26	1.97	0.64	0.39	0.47	0.55
Leverage Ratio	-12.93	-16.33	-57.68	55.45	16.14	11.81	6.04	3.27	2.71	2.88	3.05
Compound Leverage Factor	-0.25	-3.67	-8.94	44.29	8.92	77.68	4.32	2.96	2.30	-0.60	6.72
Debt to Total Capital	115.95%	105.39%	100.71%	93.83%	84.61%	85.17%	54.00%	29.13%	32.31%	36.18%	37.75%
Short-Term Debt to Total Capital	2.49%	2.10%	2.05%	2.22%	4.24%	1.41%	2.43%	0.46%	0.61%	0.05%	0.15%
Long-Term Debt to Total Capital	113.46%	103.29%	98.66%	91.60%	80.37%	83.75%	51.57%	28.67%	31.70%	36.13%	37.60%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.09%	0.16%	0.25%	0.22%	0.52%	0.64%	0.63%	0.63%	0.64%	0.71%	0.86%
Common Equity to Total Capital	-16.04%	-5.56%	-0.96%	5.96%	14.87%	14.19%	45.38%	70.25%	67.05%	63.11%	61.39%
Debt to EBITDA	7.21	6.08	6.76	5.80	3.68	20.72	1.07	0.58	1.50	4.13	9.77
Net Debt to EBITDA	6.76	5.56	6.25	5.67	3.46	19.17	0.98	0.51	1.31	3.87	9.18
Long-Term Debt to EBITDA	7.06	5.96	6.62	5.66	3.50	20.38	1.02	0.57	1.47	4.12	9.73
Debt to NOPAT	-9.95	10.90	9.60	9.09	6.49	18.42	1.54	0.85	2.53	21.20	-21.48
Net Debt to NOPAT	-9.32	9.97	8.88	8.90	6.09	17.04	1.42	0.75	2.21	19.87	-20.19
Long-Term Debt to NOPAT	-9.73	10.68	9.40	8.87	6.16	18.12	1.48	0.83	2.48	21.17	-21.39
Altman Z-Score	2.69	2.67	2.71	2.91	3.24	2.49	4.09	4.81	3.49	2.91	2.84
Noncontrolling Interest Sharing Ratio	-1.29%	-1.21%	-7.23%	7.74%	3.42%	3.80%	1.99%	1.06%	0.91%	1.02%	1.24%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.04	3.00	2.74	2.48	2.60	2.09	2.12	2.33	2.18	2.08	1.83
Quick Ratio	1.17	1.22	1.13	0.96	0.89	0.83	0.91	0.89	0.82	0.78	0.73
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	154	80	-19	-118	256	240	198	345	96	55	42
Operating Cash Flow to CapEx	2,175.63%	125.25%	-18.78%	176.62%	0.00%	1,072.97%	0.00%	516.17%	300.74%	210.15%	177.91%
Free Cash Flow to Firm to Interest Expense	1.60	0.89	-0.20	-1.19	2.75	3.14	1.28	6.34	2.78	1.28	1.08
Operating Cash Flow to Interest Expense	2.69	0.28	-0.04	0.58	2.07	3.64	0.23	9.20	10.52	4.77	2.24
Operating Cash Flow Less CapEx to Interest Expense	2.56	0.06	-0.28	0.25	2.34	3.30	0.91	7.41	7.02	2.50	0.98
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.85	1.84	2.06	2.32	2.19	1.81	2.72	2.69	2.08	1.84	1.89
Accounts Receivable Turnover	8.97	9.05	9.58	9.83	9.52	8.62	11.24	11.04	10.40	10.30	10.31
Inventory Turnover	4.02	4.09	4.72	5.13	4.74	4.22	6.30	6.15	5.17	5.13	5.69
Fixed Asset Turnover	7.65	7.25	8.30	9.67	9.69	8.05	14.01	14.94	9.75	7.50	7.33
Accounts Payable Turnover	12.17	10.48	11.01	10.98	10.47	8.41	10.70	10.90	9.06	8.33	7.92
Days Sales Outstanding (DSO)	40.71	40.31	38.09	37.15	38.36	42.33	32.47	33.05	35.08	35.45	35.39
Days Inventory Outstanding (DIO)	90.90	89.23	77.40	71.13	76.96	86.42	57.90	59.36	70.60	71.12	64.20
Days Payable Outstanding (DPO)	29.98	34.82	33.15	33.26	34.86	43.39	34.11	33.48	40.27	43.83	46.08
Cash Conversion Cycle (CCC)	101.62	94.73	82.34	75.02	80.46	85.35	56.26	58.93	65.41	62.74	53.50
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	834	842	970	1,215	1,110	916	1,132	1,220	1,296	1,263	1,199
Invested Capital Turnover	3.29	3.41	3.71	4.04	3.87	3.42	5.54	5.38	4.06	3.60	3.71
Increase / (Decrease) in Invested Capital	-257	8.40	128	245	-105	-194	216	88	76	-33	-64
Enterprise Value (EV)	1,101	1,349	1,334	1,355	1,348	1,266	1,541	1,395	1,537	1,037	1,256
Market Capitalization	141	466	364	223	420	489	947	1,061	1,147	589	810
Book Value per Share	($4.41)	($1.37)	($0.27)	$1.95	$4.57	$3.64	$13.99	$23.91	$26.51	$25.60	$23.38
Tangible Book Value per Share	($9.07)	($5.25)	($4.63)	($2.81)	$0.05	($0.65)	$9.66	$19.05	$19.74	$18.38	$16.56
Total Capital	883	914	1,038	1,229	1,160	978	1,184	1,260	1,351	1,292	1,227
Total Debt	1,024	964	1,046	1,153	982	833	639	367	437	467	463
Total Long-Term Debt	1,002	944	1,024	1,126	933	819	611	361	428	467	461
Net Debt	959	882	967	1,129	922	771	587	327	381	438	435
Capital Expenditures (CapEx)	12	20	21	33	-25	26	-107	97	121	98	49
Debt-free, Cash-free Net Working Capital (DFCFNWC)	601	603	644	847	778	527	818	788	702	599	529
Debt-free Net Working Capital (DFNWC)	665	685	723	871	837	590	871	828	758	628	557
Net Working Capital (NWC)	643	665	701	844	788	576	842	822	750	628	555
Net Nonoperating Expense (NNE)	-101	70	91	21	69	111	119	42	26	29	34
Net Nonoperating Obligations (NNO)	975	892	977	1,139	931	771	587	327	381	438	435
Total Depreciation and Amortization (D&A)	44	43	47	53	58	54	56	59	63	78	80
Debt-free, Cash-free Net Working Capital to Revenue	18.96%	21.08%	19.14%	19.22%	17.27%	15.21%	14.42%	12.46%	13.75%	13.02%	11.57%
Debt-free Net Working Capital to Revenue	21.00%	23.94%	21.47%	19.77%	18.60%	17.01%	15.34%	13.10%	14.83%	13.66%	12.18%
Net Working Capital to Revenue	20.30%	23.27%	20.84%	19.15%	17.51%	16.61%	14.84%	13.01%	14.67%	13.65%	12.13%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.02)	$0.55	$0.46	$2.84	$2.19	($1.73)	$7.67	$10.41	$4.17	($0.26)	($1.76)
Adjusted Weighted Average Basic Shares Outstanding	32.10M	37.13M	37.21M	37.45M	37.78M	38.12M	38.39M	36.99M	34.02M	31.85M	51.48M
Adjusted Diluted Earnings per Share	($0.02)	$0.54	$0.46	$2.81	$2.17	($1.73)	$7.56	$10.21	$4.10	($0.26)	($1.76)
Adjusted Weighted Average Diluted Shares Outstanding	32.10M	37.13M	37.21M	37.45M	37.78M	38.12M	38.39M	36.99M	34.02M	31.85M	51.48M
Adjusted Basic & Diluted Earnings per Share	($0.02)	$0.00	$0.00	$0.00	$2.19	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.10M	37.13M	37.21M	37.45M	37.78M	38.12M	38.39M	36.99M	34.02M	31.85M	51.48M
Normalized Net Operating Profit after Tax (NOPAT)	82	89	71	131	137	47	331	430	172	23	-19
Normalized NOPAT Margin	2.58%	3.12%	2.10%	2.97%	3.05%	1.35%	5.83%	6.81%	3.37%	0.50%	-0.42%
Pre Tax Income Margin	0.06%	0.91%	0.50%	2.65%	2.56%	-2.60%	6.86%	8.27%	3.79%	-0.16%	-1.56%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.02	1.29	1.18	1.47	2.24	-0.18	3.51	10.59	6.58	0.83	-0.83
NOPAT to Interest Expense	-1.07	0.98	1.20	1.28	1.62	0.59	2.67	7.95	4.97	0.51	-0.55
EBIT Less CapEx to Interest Expense	0.90	1.07	0.95	1.15	2.50	-0.52	4.20	8.81	3.08	-1.44	-2.09
NOPAT Less CapEx to Interest Expense	-1.19	0.76	0.96	0.95	1.89	0.25	3.36	6.17	1.47	-1.75	-1.81
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.19%	0.00%	-0.31%	2.17%	5.08%	16.94%	-339.73%	-43.74%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.19%	0.00%	-0.31%	2.78%	17.85%	94.74%	-1,038.36%	-43.74%

This table displays calculated financial ratios and metrics derived from Ryerson's official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-22.94%	-19.21%	-13.65%	-11.87%	-8.78%	-9.63%	-9.44%	-8.35%	-4.59%	3.10%	9.67%
EBITDA Growth	-74.44%	-28.33%	633.72%	-78.47%	-41.72%	-65.40%	-55.63%	21.11%	-46.24%	-18.70%	-161.79%
EBIT Growth	-78.64%	-32.11%	644.30%	-99.14%	-57.59%	-91.13%	-87.67%	333.33%	-85.77%	-103.92%	-820.75%
NOPAT Growth	-79.39%	-33.05%	276.02%	-98.95%	-59.97%	-91.00%	-94.61%	187.50%	-77.01%	-118.87%	-1,557.69%
Net Income Growth	-80.86%	-35.93%	209.24%	-115.58%	-72.61%	-117.00%	-116.15%	28.38%	-79.61%	-140.00%	-792.86%
EPS Growth	-79.22%	-31.51%	248.08%	-117.32%	-72.64%	-120.00%	-116.88%	18.18%	-79.31%	-130.00%	-807.69%
Operating Cash Flow Growth	34.85%	-47.69%	-50.39%	-159.45%	-77.54%	69.74%	2.33%	13.81%	-8.11%	-106.17%	22.23%
Free Cash Flow Firm Growth	156.62%	171.53%	60.50%	-460.20%	-186.66%	-174.99%	182.24%	164.43%	165.49%	157.00%	6.75%
Invested Capital Growth	-8.20%	-7.51%	6.24%	9.78%	12.28%	8.93%	-2.55%	-5.59%	-6.03%	-4.57%	-5.05%
Revenue Q/Q Growth	-4.45%	-7.21%	-10.77%	11.40%	-1.11%	-8.07%	-10.58%	12.74%	2.96%	-0.67%	-4.88%
EBITDA Q/Q Growth	-12.56%	-2.74%	-11.25%	-71.47%	136.67%	-42.25%	13.82%	-22.14%	5.05%	-12.66%	-186.50%
EBIT Q/Q Growth	-17.02%	-0.86%	-25.22%	-98.60%	4,000.00%	-79.27%	3.92%	-50.94%	34.62%	-105.71%	-19,000.00%
NOPAT Q/Q Growth	-17.36%	-6.52%	-18.12%	-98.34%	3,053.06%	-78.99%	-50.94%	-11.54%	152.17%	-117.24%	-3,690.00%
Net Income Q/Q Growth	-20.84%	-6.12%	-26.35%	-128.46%	239.19%	-158.25%	30.00%	-26.19%	139.62%	-785.71%	-160.42%
EPS Q/Q Growth	-16.54%	-5.66%	-23.00%	-128.57%	231.82%	-168.97%	35.00%	-38.46%	133.33%	-866.67%	-156.52%
Operating Cash Flow Q/Q Growth	43.41%	-31.22%	13.62%	-153.05%	154.18%	419.69%	-31.50%	-144.69%	157.77%	-134.87%	1,457.83%
Free Cash Flow Firm Q/Q Growth	363.19%	-9.07%	-130.21%	-183.05%	-11.43%	21.31%	133.13%	121.74%	13.28%	-31.51%	-37.95%
Invested Capital Q/Q Growth	0.02%	-1.05%	6.33%	4.31%	2.30%	-4.00%	-4.87%	1.05%	1.83%	-2.50%	-5.35%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	19.42%	20.00%	22.22%	17.56%	18.24%	17.93%	18.97%	18.00%	17.91%	17.18%	15.29%
EBITDA Margin	5.44%	5.70%	5.67%	1.45%	3.48%	2.18%	2.78%	1.92%	1.96%	1.72%	-1.57%
Operating Margin	4.34%	4.52%	3.91%	0.06%	1.86%	0.47%	0.26%	0.20%	0.50%	-0.09%	-3.43%
EBIT Margin	4.32%	4.61%	3.87%	0.05%	2.01%	0.45%	0.53%	0.23%	0.30%	-0.02%	-3.46%
Profit (Net Income) Margin	2.80%	2.83%	2.34%	-0.60%	0.84%	-0.53%	-0.42%	-0.47%	0.18%	-1.24%	-3.39%
Tax Burden Percent	75.65%	73.24%	77.61%	77.89%	77.44%	93.75%	87.50%	76.81%	-33.33%	139.81%	78.62%
Interest Burden Percent	85.69%	83.83%	77.91%	-1,583.33%	54.07%	-125.49%	-90.57%	-265.38%	-180.00%	5,150.00%	124.87%
Effective Tax Rate	24.35%	26.76%	22.39%	0.00%	22.56%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	14.24%	13.78%	12.33%	0.17%	5.32%	1.22%	0.65%	0.49%	1.15%	-0.21%	-8.92%
ROIC Less NNEP Spread (ROIC-NNEP)	12.72%	12.21%	10.14%	-1.81%	3.61%	-1.17%	-0.82%	-1.02%	0.75%	-3.08%	-11.43%
Return on Net Nonoperating Assets (RNNOA)	6.34%	5.15%	3.97%	-0.82%	1.77%	-0.55%	-0.39%	-0.55%	0.43%	-1.79%	-6.29%
Return on Equity (ROE)	20.58%	18.93%	16.30%	-0.64%	7.09%	0.67%	0.26%	-0.06%	1.58%	-2.00%	-15.21%
Cash Return on Invested Capital (CROIC)	19.52%	17.34%	7.66%	-0.09%	-4.48%	-4.33%	4.30%	7.51%	7.06%	5.20%	3.42%
Operating Return on Assets (OROA)	9.26%	9.79%	8.05%	0.09%	3.79%	0.86%	0.97%	0.39%	0.52%	-0.03%	-6.53%
Return on Assets (ROA)	6.00%	6.01%	4.87%	-1.15%	1.59%	-1.01%	-0.77%	-0.80%	0.31%	-2.21%	-6.41%
Return on Common Equity (ROCE)	20.40%	18.76%	16.15%	-0.64%	7.02%	0.66%	0.26%	-0.06%	1.56%	-1.98%	-15.02%
Return on Equity Simple (ROE_SIMPLE)	13.56%	10.94%	0.00%	10.30%	7.31%	2.75%	0.00%	-0.65%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	44	41	34	0.56	18	3.71	1.82	1.61	4.06	-0.70	-27
NOPAT Margin	3.28%	3.31%	3.04%	0.05%	1.44%	0.33%	0.18%	0.14%	0.35%	-0.06%	-2.40%
Net Nonoperating Expense Percent (NNEP)	1.52%	1.58%	2.19%	1.98%	1.71%	2.39%	1.47%	1.51%	0.40%	2.87%	2.51%
Return On Investment Capital (ROIC_SIMPLE)	-	-	2.50%	-	-	-	0.14%	0.12%	0.30%	-0.05%	-2.16%
Cost of Revenue to Revenue	80.58%	80.00%	77.78%	82.44%	81.76%	82.07%	81.03%	82.00%	82.09%	82.82%	84.71%
SG&A Expenses to Revenue	15.08%	15.48%	18.31%	17.50%	16.24%	17.48%	18.71%	17.80%	17.41%	17.26%	18.41%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	15.08%	15.48%	18.31%	17.50%	16.38%	17.46%	18.71%	17.80%	17.41%	17.26%	18.72%
Earnings before Interest and Taxes (EBIT)	58	58	43	0.60	25	5.10	5.30	2.60	3.50	-0.20	-38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	73	71	63	18	43	25	28	22	23	20	-17
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.76	1.10	1.27	1.28	0.76	0.79	0.72	0.91	0.86	0.93	1.08
Price to Tangible Book Value (P/TBV)	2.29	1.41	1.70	1.73	1.03	1.10	1.01	1.27	1.18	1.30	1.52
Price to Revenue (P/Rev)	0.27	0.18	0.22	0.23	0.14	0.14	0.13	0.16	0.16	0.16	0.18
Price to Earnings (P/E)	13.03	10.12	7.87	12.50	10.61	30.75	0.00	0.00	0.00	0.00	0.00
Dividend Yield	1.56%	2.46%	2.14%	2.21%	3.81%	3.75%	4.05%	3.27%	3.48%	3.28%	2.98%
Earnings Yield	7.67%	9.88%	12.70%	8.00%	9.42%	3.25%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.53	1.07	1.19	1.18	0.85	0.87	0.82	0.94	0.91	0.96	1.05
Enterprise Value to Revenue (EV/Rev)	0.34	0.25	0.30	0.32	0.24	0.25	0.23	0.27	0.27	0.27	0.27
Enterprise Value to EBITDA (EV/EBITDA)	7.75	6.07	5.28	7.09	6.03	7.79	9.16	10.28	12.15	13.11	26.50
Enterprise Value to EBIT (EV/EBIT)	10.27	8.36	6.73	10.04	9.34	15.76	29.12	32.00	71.65	108.52	0.00
Enterprise Value to NOPAT (EV/NOPAT)	13.35	10.79	8.92	13.40	12.67	21.53	47.02	52.09	105.55	179.01	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	3.56	2.86	4.21	6.75	7.96	5.70	5.06	5.69	5.65	18.28	14.44
Enterprise Value to Free Cash Flow (EV/FCFF)	7.50	5.94	15.96	0.00	0.00	0.00	18.83	12.19	12.50	18.04	29.81
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.46	0.41	0.48	0.55	0.59	0.62	0.57	0.61	0.62	0.63	0.61
Long-Term Debt to Equity	0.45	0.40	0.47	0.55	0.59	0.62	0.57	0.61	0.62	0.62	0.60
Financial Leverage	0.50	0.42	0.39	0.45	0.49	0.47	0.47	0.54	0.57	0.58	0.55
Leverage Ratio	3.03	2.79	2.71	2.88	2.92	2.87	2.88	3.07	3.00	3.06	3.05
Compound Leverage Factor	2.60	2.34	2.11	-45.60	1.58	-3.60	-2.61	-8.14	-5.41	157.80	3.81
Debt to Total Capital	31.37%	29.11%	32.31%	35.66%	37.21%	38.27%	36.18%	37.94%	38.32%	38.52%	37.75%
Short-Term Debt to Total Capital	0.28%	0.47%	0.61%	0.27%	0.10%	0.13%	0.05%	0.02%	0.11%	0.12%	0.15%
Long-Term Debt to Total Capital	31.10%	28.64%	31.70%	35.40%	37.12%	38.14%	36.13%	37.92%	38.22%	38.41%	37.60%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.64%	0.66%	0.64%	0.62%	0.60%	0.67%	0.71%	0.72%	0.73%	0.78%	0.86%
Common Equity to Total Capital	67.98%	70.23%	67.05%	63.71%	62.18%	61.06%	63.11%	61.34%	60.95%	60.70%	61.39%
Debt to EBITDA	1.63	1.70	1.50	2.21	2.70	3.52	4.13	4.25	5.24	5.39	9.77
Net Debt to EBITDA	1.50	1.52	1.31	2.02	2.55	3.27	3.87	3.95	4.91	5.06	9.18
Long-Term Debt to EBITDA	1.61	1.67	1.47	2.19	2.69	3.51	4.12	4.25	5.23	5.37	9.73
Debt to NOPAT	2.81	3.02	2.53	4.17	5.67	9.73	21.20	21.53	45.55	73.59	-21.48
Net Debt to NOPAT	2.59	2.71	2.21	3.81	5.36	9.04	19.87	20.03	42.68	69.12	-20.19
Long-Term Debt to NOPAT	2.78	2.98	2.48	4.14	5.66	9.70	21.17	21.52	45.43	73.37	-21.39
Altman Z-Score	3.61	3.44	3.25	2.95	2.94	2.87	2.87	2.78	2.74	2.79	2.83
Noncontrolling Interest Sharing Ratio	0.91%	0.89%	0.91%	0.94%	0.95%	1.00%	1.02%	1.06%	1.07%	1.17%	1.24%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.03	2.14	2.18	2.09	2.38	2.22	2.08	2.00	2.03	1.98	1.83
Quick Ratio	0.86	0.92	0.82	0.81	0.96	0.91	0.78	0.87	0.87	0.84	0.73
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	154	140	-42	-120	-134	-105	35	77	87	60	37
Operating Cash Flow to CapEx	249.57%	354.02%	360.40%	-234.31%	114.60%	431.41%	395.71%	-521.52%	245.36%	-79.05%	541.83%
Free Cash Flow to Firm to Interest Expense	18.57	15.07	-4.46	-11.87	-11.82	-9.14	3.45	8.13	8.92	5.93	3.91
Operating Cash Flow to Interest Expense	13.89	8.53	9.48	-4.73	2.29	11.70	9.13	-4.34	2.43	-0.82	11.86
Operating Cash Flow Less CapEx to Interest Expense	8.33	6.12	6.85	-6.75	0.29	8.99	6.82	-5.17	1.44	-1.86	9.67
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.14	2.12	2.08	1.93	1.89	1.89	1.84	1.71	1.73	1.78	1.89
Accounts Receivable Turnover	8.35	8.88	10.40	8.49	8.69	9.00	10.30	8.36	8.36	8.77	10.31
Inventory Turnover	5.23	5.33	5.17	5.11	5.19	5.53	5.13	4.90	5.12	5.40	5.69
Fixed Asset Turnover	11.88	10.87	9.75	9.14	8.50	7.98	7.50	7.35	7.26	7.20	7.33
Accounts Payable Turnover	7.62	8.79	9.06	7.20	7.80	8.27	8.33	6.75	7.68	7.66	7.92
Days Sales Outstanding (DSO)	43.72	41.12	35.08	42.98	41.98	40.53	35.45	43.68	43.65	41.63	35.39
Days Inventory Outstanding (DIO)	69.73	68.52	70.60	71.40	70.33	66.06	71.12	74.43	71.33	67.64	64.20
Days Payable Outstanding (DPO)	47.93	41.55	40.27	50.70	46.81	44.13	43.83	54.05	47.51	47.67	46.08
Cash Conversion Cycle (CCC)	65.53	68.10	65.41	63.68	65.50	62.47	62.74	64.06	67.48	61.61	53.50
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,231	1,219	1,296	1,352	1,383	1,327	1,263	1,276	1,299	1,267	1,199
Invested Capital Turnover	4.34	4.17	4.06	3.83	3.69	3.70	3.60	3.42	3.31	3.45	3.71
Increase / (Decrease) in Invested Capital	-110	-99	76	120	151	109	-33	-76	-83	-61	-64
Enterprise Value (EV)	1,884	1,305	1,537	1,598	1,174	1,155	1,037	1,203	1,182	1,215	1,256
Market Capitalization	1,510	970	1,147	1,135	670	661	589	731	694	736	810
Book Value per Share	$24.00	$25.67	$26.51	$25.88	$25.57	$25.09	$25.60	$25.24	$25.20	$24.45	$23.38
Tangible Book Value per Share	$18.45	$19.95	$19.74	$19.12	$18.88	$18.12	$18.38	$18.09	$18.22	$17.54	$16.56
Total Capital	1,263	1,257	1,351	1,395	1,412	1,364	1,292	1,311	1,331	1,297	1,227
Total Debt	396	366	437	497	525	522	467	497	510	500	463
Total Long-Term Debt	393	360	428	494	524	520	467	497	509	498	461
Net Debt	365	327	381	454	496	485	438	463	478	469	435
Capital Expenditures (CapEx)	46	22	25	20	23	31	23	7.90	9.70	11	21
Debt-free, Cash-free Net Working Capital (DFCFNWC)	708	692	702	757	778	681	599	616	643	618	529
Debt-free Net Working Capital (DFNWC)	739	731	758	800	808	718	628	651	675	648	557
Net Working Capital (NWC)	735	725	750	796	806	716	628	650	673	647	555
Net Nonoperating Expense (NNE)	6.51	5.93	7.76	7.96	7.36	9.71	6.02	6.91	1.96	14	11
Net Nonoperating Obligations (NNO)	365	327	381	454	496	485	438	463	478	469	435
Total Depreciation and Amortization (D&A)	15	14	20	17	18	20	23	19	19	20	21
Debt-free, Cash-free Net Working Capital to Revenue	12.68%	13.10%	13.75%	15.32%	16.13%	14.48%	13.02%	13.70%	14.48%	13.81%	11.57%
Debt-free Net Working Capital to Revenue	13.24%	13.83%	14.83%	16.19%	16.74%	15.27%	13.66%	14.47%	15.20%	14.49%	12.18%
Net Working Capital to Revenue	13.18%	13.72%	14.67%	16.11%	16.71%	15.23%	13.65%	14.47%	15.17%	14.45%	12.13%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.07	$1.02	$0.78	($0.22)	$0.29	($0.20)	($0.13)	($0.18)	$0.06	($0.46)	($1.18)
Adjusted Weighted Average Basic Shares Outstanding	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M	32.20M	32.20M	32.21M	51.48M
Adjusted Diluted Earnings per Share	$1.06	$1.00	$0.77	($0.22)	$0.29	($0.20)	($0.13)	($0.18)	$0.06	($0.46)	($1.18)
Adjusted Weighted Average Diluted Shares Outstanding	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M	32.20M	32.20M	32.21M	51.48M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	34.39M	34.17M	34.02M	34.34M	33.20M	31.85M	31.85M	32.20M	32.20M	32.21M	51.48M
Normalized Net Operating Profit after Tax (NOPAT)	44	41	34	0.56	19	3.57	1.82	1.61	4.06	-0.70	-27
Normalized NOPAT Margin	3.28%	3.31%	3.04%	0.05%	1.55%	0.32%	0.18%	0.14%	0.35%	-0.06%	-2.40%
Pre Tax Income Margin	3.70%	3.87%	3.01%	-0.77%	1.09%	-0.57%	-0.48%	-0.61%	-0.54%	-0.89%	-4.32%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.99	6.18	4.53	0.06	2.18	0.44	0.52	0.27	0.36	-0.02	-4.02
NOPAT to Interest Expense	5.31	4.43	3.55	0.06	1.56	0.32	0.18	0.17	0.41	-0.07	-2.79
EBIT Less CapEx to Interest Expense	1.42	3.77	1.89	-1.96	0.18	-2.27	-1.78	-0.56	-0.63	-1.06	-6.21
NOPAT Less CapEx to Interest Expense	-0.25	2.03	0.92	-1.96	-0.44	-2.39	-2.13	-0.66	-0.58	-1.11	-4.98
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	20.27%	25.26%	16.94%	27.54%	39.56%	109.61%	-339.73%	-469.23%	-179.10%	-110.09%	-43.74%
Augmented Payout Ratio	110.82%	137.58%	94.74%	94.97%	78.97%	359.83%	-1,038.36%	-1,430.77%	-447.76%	-110.09%	-43.74%

Financials Breakdown Chart

Key Financial Trends

Ryerson Holding Corp (RYZ) shows a strong end to 2025 on operating cash flow, with a stable top line but ongoing profitability challenges. Below are the key takeaways from the most recent quarterly statements (and trends over the last four years of data you provided).

Q4 2025 Net Cash From Continuing Operating Activities: $112.7M, marking a solid improvement in cash generation from core operations.
Q4 2025 net cash impact from operating assets/liabilities: $121.9M added to cash, driven by changes in working capital.
Revenue stability in 2025 quarters: quarterly operating revenue around the $1.1B–$1.17B range (Q2 2025: $1,169.3M; Q3 2025: $1,161.5M; Q4 2025: $1,104.8M), indicating a durable top line.
Shareholder return: cash dividends per share of $0.1875 (Q4 2025), illustrating ongoing distributions to shareholders.
Near-term liquidity signal: Total current assets around $1.303B and total current liabilities around $0.657B in Q3 2025, implying a rough current ratio near 2x.

Gross margin range in 2025: gross margins hovering in the mid-teens (roughly 15–18% across quarters), suggesting steady profitability but with room for margin improvement.
Balance sheet scale: Long-term debt around $0.50B (roughly $498–$509M in 2025) against total assets near $2.49B and total equity near $0.8B.
Cash balance trend: cash and cash equivalents generally in the $20–$35M range across 2024–2025 quarters, indicating a modest liquidity cushion beyond CFO (not a large cash hoard).

Net income volatility and losses: quarterly net income from continuing operations has been negative in most recent quarters (Q4 2025: -$37.9M; Q3 2025: -$14.4M; Q1 2025: -$5.3M), underscoring ongoing profitability challenges.
Financing pressure: substantial net cash outflows from financing in several quarters (Q4 2025 net financing outflow: -$93.3M), including debt repayments and dividend payments, which can pressure liquidity if not offset by CFO/financing activities.

05/05/26 06:01 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Ryerson's Financials

When does Ryerson's fiscal year end?

According to the most recent income statement we have on file, Ryerson's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has Ryerson's net income changed over the last 10 years?

Ryerson's net income appears to be on an upward trend, with a most recent value of -$55.10 million in 2025, rising from -$1.80 million in 2015. The previous period was -$7.30 million in 2024. Find out what analysts predict for Ryerson in the coming months.

What is Ryerson's operating income?

Ryerson's total operating income in 2025 was -$30.80 million, based on the following breakdown:

Total Gross Profit: $782.20 million
Total Operating Expenses: $813 million

How has Ryerson's revenue changed over the last 10 years?

Over the last 10 years, Ryerson's total revenue changed from $3.17 billion in 2015 to $4.57 billion in 2025, a change of 44.3%.

How much debt does Ryerson have?

Ryerson's total liabilities were at $1.64 billion at the end of 2025, a 1.6% increase from 2024, and a 2.7% decrease since 2015.

How much cash does Ryerson have?

In the past 10 years, Ryerson's cash and equivalents has ranged from $11 million in 2019 to $80.70 million in 2016, and is currently $26.90 million as of their latest financial filing in 2025.

How has Ryerson's book value per share changed over the last 10 years?

Over the last 10 years, Ryerson's book value per share changed from -4.41 in 2015 to 23.38 in 2025, a change of -630.0%.

Related Companies

Financial statements for NYSE:RYZ last updated on 4/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ryerson (RYZ) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Ryerson's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ryerson (RYZ) Financials

Annual Income Statements for Ryerson

Quarterly Income Statements for Ryerson

Annual Cash Flow Statements for Ryerson

Quarterly Cash Flow Statements for Ryerson

Annual Balance Sheets for Ryerson

Quarterly Balance Sheets for Ryerson

Annual Metrics And Ratios for Ryerson

Quarterly Metrics And Ratios for Ryerson

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Ryerson's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools